Buy SNOA by Nov 5, 2026.

Sonoma Pharmaceuticals ($SNOA) just dropped one of its strongest quarters in years U.S. sales up +141%, that alone tells you something has clearly shifted Revenue came in strong, margins improved, and they even turned EBITDA positive for the first time. That's a real change in direction They're sitting on around $5M cash, which is decent for their size, especially with costs staying under control while growth is picking up Also worth keeping in mind: This company has a history of …